Genesis Models ED1 & ED2: Case Study Model ED1 Installed on Desalter at Refinery
30 Jan 2025
Read more >Absolute Antibody, Chief Operating Officer, Dr. Catherine Bladen, shares an update on lab activities amid the COVID-19 pandemic.
The team are still in the lab practicing social distancing, currently focusing on anitibodies specific to the Coronavirus outbreak.
By Absolute Antibody Research & Manufacturing
1157 Views